Certified by Founder Lodge
Coave Therapeutics
France - PARIS
START UP
1 Disclosed Funding Rounds $32,000,000
0 Participating Investments
-
Founded date
2014
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases.
We are pushing the
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 09 ,2025 | Series A | $32,000,000 |
Omnes
UI Investissement
Turenne Groupe
Kurma Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
XCENA | $135,000,000 | (Jun 2, 2026)
Voxmind | $735,203 | (Jun 2, 2026)
Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
SpeedLabs | $6,500,000 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)
